Obesity drug developer BioAge Labs aims up to $640…
(Reuters) -BioAge Labs is eyeing a valuation of up to $639.7 million in its upsized initial public…
(Reuters) -BioAge Labs is eyeing a valuation of up to $639.7 million in its upsized initial public…
By Jonathan Stempel(Reuters) - Elon Musk and X asked a federal judge to dismiss former CNN anchor…
(This Sept. 23 story has been refiled to say 'Metals producer,' not 'Miner,' in…
By Trevor Hunnicutt and Julie SteenhuysenWASHINGTON (Reuters) - U.S. President Joe Biden announced…
By Allison Lampert(Reuters) - Boeing said on Tuesday it has offered to extend the timeline for a…
WASHINGTON (Reuters) - U.S. single-family home prices edged up in July, but the overall trend is…
By Ankur Banerjee and Sruthi ShankarSINGAPORE/LONDON (Reuters) - World stocks hit a record high on…
By Nell MackenzieLONDON (Reuters) - The largest players now make up about three-quarters of the…
(Reuters) - Federal Reserve Bank of Chicago President Austan Goolsbee on Monday said he expects…
WASHINGTON (Reuters) - The head of the Federal Aviation Administration will tell Congress on Tuesday…
Discover new market trends and ideas directly to your inbox.
Welcome, Login to your account.
Welcome, Create your new account
A password will be e-mailed to you.